Follow
Boris Turk
Boris Turk
Professor of Biochemistry, Head of Department of Biochemistry and Molecular and Structural Biology
Verified email at ijs.si
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, DJ (Klionsky, FC Abdalla, FC (Abdalla, ...
Autophagy 8 (4), 445-544, 2012
13930*2012
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
60932018
Targeting proteases: successes, failures and future prospects
B Turk
Nature reviews Drug discovery 5 (9), 785-799, 2006
17362006
Cysteine cathepsins: from structure, function and regulation to new frontiers
V Turk, V Stoka, O Vasiljeva, M Renko, T Sun, B Turk, D Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 68-88, 2012
15672012
Lysosomal cysteine proteases: more than scavengers
B Turk, D Turk, V Turk
Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 2000
11552000
Lysosomal cysteine proteases: facts and opportunities
V Turk, B Turk, D Turk
The EMBO journal, 2001
10442001
Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route
V Stoka, B Turk, SL Schendel, TH Kim, T Cirman, SJ Snipas, LM Ellerby, ...
Journal of Biological Chemistry 276 (5), 3149-3157, 2001
8772001
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
B Turk, V Turk, D Turk
Biological chemistry 378 (3-4), 141-150, 1997
6401997
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins
T Cirman, K Orešić, GD Mazovec, V Turk, JC Reed, RM Myers, ...
Journal of Biological Chemistry 279 (5), 3578-3587, 2004
6042004
Emerging roles of cysteine cathepsins in disease and their potential as drug targets
O Vasiljeva, T Reinheckel, C Peters, D Turk, V Turk, B Turk
Current pharmaceutical design 13 (4), 387-403, 2007
5802007
Lysosomes and lysosomal cathepsins in cell death
U Repnik, V Stoka, V Turk, B Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 22-33, 2012
4632012
Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues
G Droga-Mazovec, L Bojic, A Petelin, S Ivanova, U Repnik, GS Salvesen, ...
Journal of Biological Chemistry 283 (27), 19140-19150, 2008
4552008
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment
G Mikhaylov, U Mikac, AA Magaeva, VI Itin, EP Naiden, I Psakhye, ...
Nature nanotechnology 6 (9), 594-602, 2011
4362011
Cysteine cathepsins and extracellular matrix degradation
M Fonović, B Turk
Biochimica et Biophysica Acta (BBA)-general subjects 1840 (8), 2560-2570, 2014
3982014
Lysosomal cathepsins and their regulation in aging and neurodegeneration
V Stoka, V Turk, B Turk
Ageing research reviews 32, 22-37, 2016
3722016
Cysteine cathepsins and their extracellular roles: shaping the microenvironment
E Vidak, U Javoršek, M Vizovišek, B Turk
Cells 8 (3), 264, 2019
3612019
Protease signalling: the cutting edge
B Turk, D Turk, V Turk
The EMBO journal 31 (7), 1630-1643, 2012
3502012
Lysosomes as “suicide bags” in cell death: myth or reality?
B Turk, V Turk
Journal of Biological Chemistry 284 (33), 21783-21787, 2009
3332009
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators
B Turk, D Turk, GS Salvesen
Current pharmaceutical design 8 (18), 1623-1637, 2002
3272002
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D Turk, V Janjić, I Štern, M Podobnik, D Lamba, SW Dahl, C Lauritzen, ...
The EMBO journal, 2001
3242001
The system can't perform the operation now. Try again later.
Articles 1–20